In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...
AstraZeneca’s rare disease firm Alexion is set to expand its genomic medicine portfolio with the acquisition of gene editing specialist LogicBio Therapeutics, in a deal worth approximately $68 million ...
Ever since federal agents arrived in Chicago in early September, “typical is no longer a thing,” said Block Club Chicago reporter Francia Garcia Hernandez. The tips pour in at all hours: sightings of ...
British scientists are developing gene-edited chickens designed to be resistant to flu in hopes of protecting flocks and preventing the spread of the deadly virus to humans, Successful Farming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results